PBH EPS was $1.27, missing estimates of $1.41. Sales of $1.64B missed estimates of $1.71B. EBITDA of $158.8M was 2% short of estimates. EPS fell 10c per share, revenue rose 1.3%. Specialty foods did well, but distribution sales fell 6.8%. EBITDA rose 12%. Not great results, but strong growth is still expected in 2024.
WELL EPS of 5c missed estimates of 6.5c. Sales of $204.4M were 3% ahead of estimates. EBITDA of $28.2M was 1% short. Revenue guidance was raised to $755M to $765M, versus $740M prior. Margins were 46.1%, down from 50.2%. Sales guidance for 2024 was for more than $900M, not including any acquisitions. Despite some mixed results, the outlook does look good here, still.